Azierta fully integrated into QbD Group
Azierta fully integrated into QbD Group
Monday, 10 February 2025
QbD Group
Share
\
\
X (Twitter) 
\
\
LinkedIn 
\
\
WhatsApp 
\
\
Copy link 
\
\
Mail
As of February 2025, Azierta is fully integrated into QbD Group, marking a significant milestone in our journey to becoming a global leader in life sciences consultancy. This integration brings expanded services, international opportunities, and a stronger presence in key markets - delivering more value to both clients and employees.
Play
Azierta fully integrated into QbD Group | QbD Group
AI-generated audio
1:47
What does this change mean?
This integration is more than a name change, it’s a transformation that strengthens our combined expertise, delivering greater value to our clients and employees while enhancing our ability to support life sciences companies worldwide.
For our clients: a more comprehensive, global partner
- End-to-end expertise:
Access to a broader service portfolio covering regulatory affairs, compliance, medical devices, in vitro diagnostics (IVD), pharmacovigilance, and clinical services.
- Stronger global reach:
Azierta’s expertise in Spain now integrates with QbD Group’s footprint in Belgium, the U.S., Latin America, and Asia, offering seamless regulatory and product development support across borders.
- Consistent excellence:
The same trusted team you rely on, now backed by enhanced resources and capabilities.
For our employees: new career and growth opportunities
- International collaboration:
Work with global teams on diverse projects across different markets.
- Career development:
Gain access to new training, mentorship, and skill-building initiatives.
- A unified, strong culture:
Aligned values foster collaboration, innovation, and professional growth.
The integration of Azierta into QbD Group marks a significant opportunity for our employees. This transition fosters a more dynamic, innovative, and inclusive workplace where everyone can grow, collaborate, and thrive.
– Pilar Rotaeche, HR Director
A unified vision: insights on the integration
Client-centric growth
This integration strengthens Azierta’s ability to drive innovation and provide comprehensive solutions that address the evolving needs of the life sciences industry. Our expanded service portfolio ensures that we remain a trusted partner in regulatory compliance, product development, and market access.
Unlocking new opportunities
From a business perspective, this integration strengthens client relationships and unlocks new cross-selling opportunities. Azierta’s expertise in regulatory affairs and pharmacovigilance now complements QbD Group’s strengths in medical devices, IVD, and clinical services, offering a seamless, integrated approach.
This integration positions us as a one-stop shop for life sciences consultancy. We’re not just offering individual services - we’re providing comprehensive solutions that support the entire product lifecycle.
- Antonio Borregón, Business Developer
Looking ahead: a stronger future as QbD Group
With Azierta now fully part of QbD Group, we are reinforcing our commitment to delivering unparalleled value to clients, fostering a strong workplace culture, and driving innovation across the life sciences sector.
Get in touch!
Interested in what QbD Group can do for you?
More latest news
Previous
Corporate
18 Jan 2021
New Partnership: QUERCUS Labo (QC) Joins QbD Group
We’re very proud to inform you that we’ve added yet another partner to the QbD Group: QUERCUS Labo...
Corporate
8 Jan 2024
Salma Michor assumes role as Regulatory Affairs Division Head at the QbD Group
We are happy to announce that Salma Michor is our new Head of Regulatory Affairs (RA), stepping...
Corporate
3 Feb 2025
QbD Group strengthens global leadership with the appointment of Almudena del Castillo as Division Head of Vigilance & Country Manager for Spain
Corporate
6 May 2025
Dr. Angeles Escarti-Nebot joins QbD Group as Division Head Regulatory Affairs
Navigating complexity with purpose and clarity
Corporate
30 Oct 2023
QbD Group’s Salma Michor Honored as 2023 RAPS Fellow
Our colleague Salma Michor has been named a 2023 RAPS Fellow for her exceptional leadership and...
Corporate
18 Jan 2021
New Partnership: QUERCUS Labo (QC) Joins QbD Group
We’re very proud to inform you that we’ve added yet another partner to the QbD Group: QUERCUS Labo...
Corporate
8 Jan 2024
Salma Michor assumes role as Regulatory Affairs Division Head at the QbD Group
We are happy to announce that Salma Michor is our new Head of Regulatory Affairs (RA), stepping...
Corporate
3 Feb 2025
QbD Group strengthens global leadership with the appointment of Almudena del Castillo as Division Head of Vigilance & Country Manager for Spain
Corporate
6 May 2025
Dr. Angeles Escarti-Nebot joins QbD Group as Division Head Regulatory Affairs
Navigating complexity with purpose and clarity
Corporate
30 Oct 2023
QbD Group’s Salma Michor Honored as 2023 RAPS Fellow
Our colleague Salma Michor has been named a 2023 RAPS Fellow for her exceptional leadership and...
Corporate
18 Jan 2021
New Partnership: QUERCUS Labo (QC) Joins QbD Group
We’re very proud to inform you that we’ve added yet another partner to the QbD Group: QUERCUS Labo...
Corporate
8 Jan 2024
Salma Michor assumes role as Regulatory Affairs Division Head at the QbD Group
We are happy to announce that Salma Michor is our new Head of Regulatory Affairs (RA), stepping...
Next
- 1
- 2
- 3
Stay ahead in life sciences
Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.
Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.
Twitter Widget Iframe